Insmed's Series B - III Round

Insmed raised a round of funding on October 01, 1998.

Insmed is a biopharmaceutical company dedicated to improving the lives of patients battling serious rare diseases. Insmed is focused on the development and commercialization of ARIKAYCE, or liposomal …

Articles about Insmed's Series B - III Round: